drugset / Trial / NCT01925469

Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram

NCT01925469 ↗

Phase 4 Completed 30 enrolled University of Pennsylvania
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to assess the utility of benzocaine spray versus a placebo spray in alleviating pain during and after hysterosalpingogram (HSG).

Timeline

Start
2011-12
Primary completion
2012-04
Completion
2012-04

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Benzocaine vs Saline Spray; p = 0.43; Wilcoxon (Mann-Whitney) NCT01925469 ↗

paper The use of benzocaine spray does not significantly improve pain relief during HSG nor does it hasten resolution of pain post HSG. PMID 24745839 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzocaine Small molecule 14 % —

Indications

No indication recorded.